BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2912958)

  • 1. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function.
    Smith LM; Mendenhall NP; Cicale MJ; Block ER; Carter RL; Million RR
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):79-84. PubMed ID: 2912958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
    Bossi G; Cerveri I; Volpini E; Corsico A; Baio A; Corbella F; Klersy C; Arico M
    Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study.
    Horning SJ; Adhikari A; Rizk N; Hoppe RT; Olshen RA
    J Clin Oncol; 1994 Feb; 12(2):297-305. PubMed ID: 7509383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function tests after whole-lung irradiation and doxorubicin in patients with osteogenic sarcoma.
    Ellis ER; Marcus RB; Cicale MJ; Springfield DS; Bova FJ; Graham-Pole J; Enneking WF; Spanier SS; Million RR
    J Clin Oncol; 1992 Mar; 10(3):459-63. PubMed ID: 1740684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late pulmonary toxicity after treatment for Hodgkin's disease.
    Villani F; De Maria P; Bonfante V; Viviani S; Laffranchi A; Dell'oca I; Dirusso A; Zanini M
    Anticancer Res; 1997; 17(6D):4739-42. PubMed ID: 9494599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantation.
    Gandola L; Siena S; Bregni M; Sverzellati E; Piotti P; Stucchi C; Gianni AM; Lombardi F
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):743-9. PubMed ID: 1976614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
    Mefferd JM; Donaldson SS; Link MP
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):679-85. PubMed ID: 2466027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late effects on pulmonary function of mantle-field irradiation, chemotherapy or combined modality therapy for Hodgkin's disease.
    Jensen BV; Carlsen NL; Groth S; Nissen NI
    Eur J Haematol; 1990 Mar; 44(3):165-71. PubMed ID: 2328789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease.
    Hirsch A; Vander Els N; Straus DJ; Gomez EG; Leung D; Portlock CS; Yahalom J
    J Clin Oncol; 1996 Apr; 14(4):1297-305. PubMed ID: 8648387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of long-term pulmonary manifestations of mantle irradiation.
    Shapiro SJ; Shapiro SD; Mill WB; Campbell EJ
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):707-14. PubMed ID: 2211219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease.
    do Pico GA; Wiley AL; Rao P; Dickie HA
    Chest; 1979 Jun; 75(6):688-92. PubMed ID: 436520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
    Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of pulmonary function in Hodgkin's lymphoma patients.
    Ng AK; Li S; Neuberg D; Chi R; Fisher DC; Silver B; Mauch PM
    Ann Oncol; 2008 Oct; 19(10):1754-8. PubMed ID: 18467315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for lung toxicity in pediatric cancer survivors].
    López Andreu JA; Compte Torrero L; Ferrís Tortajada J; Domenech Clar R; Pérez Tarazona S; Pellicer Porres C; Cortina Orts H; Roqués Serradilla JM
    An Esp Pediatr; 1999 Nov; 51(5):505-11. PubMed ID: 10652802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function impairment in long-term survivors of Hodgkin's disease.
    Lund MB; Kongerud J; Nome O; Abrahamsen AF; Bjørtuft O; Forfang K; Boe J
    Ann Oncol; 1995 May; 6(5):495-501. PubMed ID: 7545431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary morbidity 10-18 years after irradiation for Hodgkin's disease.
    Hassink EA; Souren TS; Boersma LJ; Peerboom PF; Melkert R; van Zandwijk N; Lebesque JV; Bruning PF
    Eur J Cancer; 1993; 29A(3):343-7. PubMed ID: 8398331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects on pulmonary function of mantle radiotherapy in patients with Hodgkin's disease.
    Gustavsson A; Eskilsson J; Landberg T; Larusdottir H; Svahn-Tapper G; White T; Wollmer P
    Ann Oncol; 1992 Jun; 3(6):455-61. PubMed ID: 1498064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of thoracic radiotherapy on pulmonary function in lung cancer.
    Choi NC; Kanarek DJ
    Lung Cancer; 1994 Mar; 10 Suppl 1():S219-30. PubMed ID: 8087514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin's disease.
    Villani F; Fede Catania A; Laffranchi A; Maffioli L; Viviani S; Bonfante V
    Cancer Invest; 2003 Apr; 21(2):185-92. PubMed ID: 12743983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group.
    Fryer CJ; Hutchinson RJ; Krailo M; Collins RD; Constine LS; Hays DM; Heller RM; Davis PC; Nachman J; O'Brien RT
    J Clin Oncol; 1990 Dec; 8(12):1971-80. PubMed ID: 1700080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.